Holen Sie sich die Stockscreener-App
8.24
5.50%
-0.48
Schlusskurs vom Vortag:
$8.72
Offen:
$8.59
24-Stunden-Volumen:
75,828
Relative Volume:
0.78
Marktkapitalisierung:
$170.94M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.37%
1M Leistung:
+12.72%
6M Leistung:
+16.88%
1J Leistung:
+1.10%
1-Tages-Spanne:
$8.14
$8.80
1-Wochen-Bereich:
$8.14
$9.22
52-Wochen-Spanne:
$5.47
$11.99
Actuate Therapeutics Inc Stock (ACTU) Company Profile
Firmenname
Actuate Therapeutics Inc
Sektor
Branche
Telefon
847-986-4190
Adresse
1751 RIVER RUN, FORT WORTH
Vergleichen Sie ACTU mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACTU
Actuate Therapeutics Inc
|
8.24 | 180.90M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Actuate Therapeutics Inc Stock (ACTU) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-26 | Eingeleitet | B. Riley Securities | Buy |
| 2025-04-22 | Eingeleitet | Craig Hallum | Buy |
| 2025-03-17 | Eingeleitet | H.C. Wainwright | Buy |
Actuate Therapeutics Inc Aktie (ACTU) Neueste Nachrichten
Combining price and volume data for Actuate Therapeutics Inc.Swing Trade & Free Expert Verified Stock Movement Alerts - Newser
What data driven models say about Actuate Therapeutics Inc.’s futureTrade Signal Summary & High Win Rate Trade Tips - Newser
Chart overlay techniques for tracking Actuate Therapeutics Inc.2025 Breakouts & Breakdowns & Weekly Breakout Opportunity Watchlist - Newser
How to track smart money flows in Actuate Therapeutics Inc.Weekly Stock Summary & Daily Technical Stock Forecast Reports - Newser
Is a relief rally coming for Actuate Therapeutics Inc. holdersWeekly Profit Summary & Reliable Intraday Trade Alerts - Newser
Can Actuate Therapeutics Inc. be recession proofJuly 2025 Retail & Weekly Hot Stock Watchlists - خودرو بانک
Is Actuate Therapeutics Inc. forming a double bottomQuarterly Risk Review & Free Low Drawdown Momentum Trade Ideas - خودرو بانک
Is Actuate Therapeutics Inc. impacted by rising ratesWeekly Investment Summary & Weekly Stock Breakout Alerts - خودرو بانک
Comparing Actuate Therapeutics Inc. in custom built stock radars2025 Big Picture & Advanced Swing Trade Entry Plans - Newser
Regression analysis insights on Actuate Therapeutics Inc. performanceEarnings Risk Summary & Expert Curated Trade Setup Alerts - Newser
Will Actuate Therapeutics Inc. stock go up soonShort Setup & Long Hold Capital Preservation Plans - Newser
Backtesting results for Actuate Therapeutics Inc. trading strategies2025 Price Action Summary & Risk Adjusted Buy/Sell Alerts - Newser
Can volume confirm reversal in Actuate Therapeutics Inc.July 2025 Patterns & Free Community Consensus Stock Picks - Newser
Real time social sentiment graph for Actuate Therapeutics Inc.Market Growth Report & Technical Analysis for Trade Confirmation - Newser
Predicting Actuate Therapeutics Inc. trend using moving averagesWeekly Trade Recap & Precise Trade Entry Recommendations - Newser
Identifying reversal signals in Actuate Therapeutics Inc.2025 Momentum Check & Risk Adjusted Swing Trade Ideas - Newser
Leading vs lagging indicators on Actuate Therapeutics Inc. performanceAnalyst Downgrade & Consistent Return Strategy Ideas - Newser
Can a trend reversal in Actuate Therapeutics Inc. lead to recoveryPortfolio Return Summary & Fast Gaining Stock Strategy Reports - Newser
What makes Actuate Therapeutics Inc. stock price move sharplyDay Trade & Weekly Market Pulse Updates - Newser
Can Actuate Therapeutics Inc. recover in the next quarterJuly 2025 Price Swings & Weekly Hot Stock Watchlists - Newser
Forecasting Actuate Therapeutics Inc. price range with options data2025 Retail Activity & Low Risk Entry Point Tips - Newser
Has Actuate Therapeutics Inc. formed a bullish divergenceSell Signal & Free Safe Capital Growth Stock Tips - Newser
Using economic indicators to assess Actuate Therapeutics Inc. potentialJuly 2025 Selloffs & Safe Entry Momentum Tips - Newser
Short interest data insights for Actuate Therapeutics Inc.Weekly Profit Summary & Weekly High Potential Stock Alerts - Newser
How to read the order book for Actuate Therapeutics Inc.Gap Up & Consistent Profit Focused Trading Strategies - Newser
Exit strategy if you’re trapped in Actuate Therapeutics Inc.July 2025 Selloffs & Technical Confirmation Trade Alerts - Newser
Is Actuate Therapeutics Inc. still worth holding after the dipSell Signal & Daily Growth Stock Investment Tips - Newser
Actuate Therapeutics files $250M mixed securities shelf - MSN
Combining machine learning predictions for Actuate Therapeutics Inc.2025 Key Highlights & Capital Protection Trading Alerts - Newser
What technical models suggest about Actuate Therapeutics Inc.’s comebackJuly 2025 Action & Long-Term Growth Stock Strategies - Newser
When is the best time to exit Actuate Therapeutics Inc.Earnings Summary Report & Weekly Top Gainers Alerts - Newser
Should I set a stop loss on Actuate Therapeutics Inc.Trade Entry Report & Technical Entry and Exit Alerts - خودرو بانک
Can Actuate Therapeutics Inc. lead its sector in growthOil Prices & Safe Capital Growth Stock Tips - خودرو بانک
Is Actuate Therapeutics Inc. forming a bottoming baseWeekly Risk Summary & Weekly Market Pulse Alerts - Newser
Actuate Therapeutics Inc. Facing Inflection Point in Trend Analysis getLinesFromResByArray error: size == 0 - kangso.co.kr
Published on: 2025-09-01 18:50:37 - خودرو بانک
Stock Analysis: Is Actuate Therapeutics Inc. impacted by rising ratesMarket Sentiment Report & Verified Short-Term Plans - خودرو بانک
Finanzdaten der Actuate Therapeutics Inc-Aktie (ACTU)
Es liegen keine Finanzdaten für Actuate Therapeutics Inc (ACTU) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):